Saccharomyces cerevisiae septin mutants have pleiotropic defects, which inc
lude the formation of abnormally elongated buds. This bud morphology result
s at least in part from a cell cycle delay imposed by the Cdc28p-inhibitory
kinase Swe1p. Mutations in three other genes (GIN4, encoding a kinase rela
ted to the Schizosaccharomyces pombe mitotic inducer Nim1p; CLA4, encoding
a p21-activated kinase; and NAP1, encoding a Clb2p-interacting protein) als
o produce perturbations of septin organization associated with an Swe1p-dep
endent cell cycle delay. The effects of gin4, cla4, and nap1 mutations are
additive, indicating that these proteins promote normal septin organization
through pathways that are at least partially independent. In contrast, mut
ations affecting the other two Nim1p-related kinases in S. cerevisiae, Hsl1
p and Kcc4p, produce no detectable effect on septin organization. However,
deletion of HSL1, but not of KCC4, did produce a cell cycle delay under som
e conditions; this delay appears to reflect a direct role of Hsl1p in the r
egulation of Swe1p. As shown previously, Swe1p plays a central role in the
morphogenesis checkpoint that delays the cell cycle in response to defects
in bud formation. Swe1p is localized to the nucleus and to the daughter sid
e of the mother bud neck prior to its degradation in G(2)/M phase. Both the
neck localization of Swe1p and its degradation require Hsl1p and its bindi
ng partner Hsl7p, both of which colocalize with Swe1p at the daughter side
of the neck. This localization is lost in mutants with perturbed septin org
anization, suggesting that the release of Hsl1p and Hsl7p from the neck may
reduce their ability to inactivate Swe1p and thus contribute to the G(2) d
elay observed in such mutants. In contrast, treatments that perturb actin o
rganization have little effect on Hsl1p and Hsl7p localization, suggesting
that such treatments must stabilize Swe1p by another mechanism. The apparen
t dependence of Swe1p degradation on localization of the Hsl1p-Hsl7p-Swe1p
module to a site that exists only in budded cells may constitute a mechanis
m for deactivating the morphogenesis checkpoint when it is no longer needed
(i.e., after a bud has formed).